The Partnering Agreements with Viropharma report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story
The Partnering Agreements with Viropharma report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Read the full story
Shire has agreed to pay $4.2 billion in cash for the acquisition of ViroPharma.